ArticleJournal of molecular modeling2026
Specific interactions between fluorinated vitamin-D
Article in Journal of molecular modeling, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Vitamin D in Cardiovascular Medicine: From Molecular Mechanisms to Clinical Translation.Nutrients · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
contextVarious vitamin D
methodsThe structures of our target VD3 derivatives were optimized using the B3LYP/6-31G(d,p) method of Gaussian 16 (G16). The charge distributions of the optimized structures were calculated by constrained electrostatic potential (RESP) analysis using the HF/6-31G(d) method of G16. The RESP charges were used for describing the electrostatic interactions between each derivative and the VDR residues in classical molecular mechanics (MM) and molecular dynamics (MD) calculations. As the initial structure of VDR, the X-ray crystal structure (PDB ID: 1DB1) was used, and by using the fitting tool (gmx confrms) of the MD simulation program GROMACS, the initial structures of the VDR - derivative complexes were created. To obtain their stable structures, the classical MM method of AMBER18 was used. The tleap command of AMBER18 was employed for adding hydrogen and fluorine atoms to the PDB structure and generating solvation water molecules within 8 Å around the complex. This solvated structure of the complex was optimized using the MM method by considering water molecules explicitly. In the MM optimizations, the AMBER14SB force field, the generalized AMBER force field, and the TIP3P model were assigned for VDR, derivatives, and water molecules, respectively. We furthermore conducted MD simulations (100 ns at 300 K) for the MM optimized structures using the same force fields and confirmed the stability of the complex. Finally, to elucidate the specific interactions between VDR and each VD3 derivative at an electronic level, we investigated the electronic properties of the complexes in explicit water using the ab initio fragment molecular orbital (FMO) method. We employed the ab initio MP2/6-31G(d) method of the FMO calculation program ABINIT-MP Ver6.0, to accurately investigate the π-π stacking, NH-π, and CH-π interactions as well as the hydrogen-bonding and electrostatic interactions between the VDR residues and the derivatives. Furthermore, to highlight the critical VDR residues for the binding between VDR and the derivative, we investigated the inter-fragment interaction energies obtained by the FMO calculations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.